 SAN CARLOS, Calif., Sept. 10, 2021 GLOBE NEWSWIRE -- BioCardia, Inc. Nasdaq: BCDA, a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces data from its CardiAMP Cell Therapy Heart Failure pivotal trial ClinicalTrials.gov Identifier: NCT02438306, which are being presented at the Heart Failure Society of America Annual Meeting 2021 on Saturday, September 11. This years meeting provides a hybrid format; in-person at the Gaylord Rockies in Denver, Colorado or global live on-line access. 